Research by Isabelle Gagnon-Arpin

(Displaying 1 to 20 of 27) | Page: 1 2 | Next »
In this issue briefing, the authors discuss how different strategies are needed to counter the burden of cardiovascular disease in Saudi Arabia. Large-scale public health interventions...
The Conference Board of Canada | 20 pages | January 2021 | by Isabelle Gagnon-Arpin, Junyi Feng
In this issue briefing, the authors model the economic burden of cardiovascular disease in Mexico—the direct costs of delivering health care services and the indirect costs from...
The Conference Board of Canada | 19 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors model the economic burden of cardiovascular disease in the United Arab Emirates—the direct costs of delivering health care services and the...
The Conference Board of Canada | 18 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors discuss how different strategies are needed to counter the burden of cardiovascular disease in Saudi Arabia. Large-scale public health interventions...
The Conference Board of Canada | 19 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors discuss how different strategies are needed to counter the burden of cardiovascular disease in Mexico. Large-scale public health interventions...
The Conference Board of Canada | 19 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors discuss how different strategies are needed to counter the burden of cardiovascular disease in Colombia. Large-scale public health interventions...
The Conference Board of Canada | 19 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors discuss how different strategies are needed to counter the burden of cardiovascular disease in the United Arab Emirates. Large-scale public...
The Conference Board of Canada | 18 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors model the economic burden of cardiovascular disease in Colombia—the direct costs of delivering health care services and the indirect costs from...
The Conference Board of Canada | 20 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
This report examines cancer mortality rates in Canada, with a focus on lung, colorectal, and prostate cancers, and compares our national and provincial rates against those of 16...
The Conference Board of Canada | 30 pages | December 2020 | by Junyi Feng, Isabelle Gagnon-Arpin, Monika Slovinec D’Angelo
Disease-modifying therapies (DMTs) slow down brain lesions and ease relapses in multiple sclerosis patients—but why can’t Canadians easily access them? This primer examines DMTs’...
The Conference Board of Canada | 48 pages | December 2020 | by Junyi Feng, Isabelle Gagnon-Arpin, Nicholas Moroz, Monika Slovinec D’Angelo
Les immunomodulateurs ralentissent les lésions au cerveau et diminuent la fréquence des poussées chez les patients atteints de la sclérose en plaques. Alors, pourquoi les Canadiens...
Le Conference Board du Canada | 53 pages | December 2020 | by Junyi Feng, Isabelle Gagnon-Arpin, Nicholas Moroz, Monika Slovinec D’Angelo
Which interventions may yield the biggest health and economic impacts on cardiovascular disease (CVD) in Brazil? This issue briefing assesses the impact of two different, yet complementary,...
The Conference Board of Canada | 20 pages | December 2020 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors examine the direct and indirect costs of cardiovascular disease and their impact on the public health care system and economy of Brazil, from...
The Conference Board of Canada | 22 pages | December 2020 | by Junyi Feng, Isabelle Gagnon-Arpin
Will Canada be able to keep up with Canada’s growing eye needs? This impact paper quantifies the value of ophthalmology from a population health, health care system, and broader...
The Conference Board of Canada | 37 pages | November 2020 | by Isabelle Gagnon-Arpin, Nicholas Moroz, Monika Slovinec D’Angelo, Zhenzhen Ye
This impact paper identifies the contribution that various health care cost drivers, including COVID-19, have on projections for health care expenditures in Canada.
The Conference Board of Canada | 49 pages | October 2020 | by Isabelle Gagnon-Arpin, Greg Hermus
Ce document évalue l’impact des divers facteurs de croissance des coûts des soins de santé, dont la COVID-19, sur les projections des dépenses de santé au Canada.
The Conference Board of Canada | 55 pages | October 2020 | by Isabelle Gagnon-Arpin, Greg Hermus
The retail price paid for pharmaceuticals is a result of several different inputs, few of which are well understood by consumers. Pharmacy mark-ups are especially elusive, as they...
The Conference Board of Canada | Recorded Webinar | October 2018 | by Isabelle Gagnon-Arpin
This briefing explores the inputs and costs that are reflected in the final retail cost of pharmaceuticals, sheds light on how pharmacy markups are determined, and discusses key...
The Conference Board of Canada | 43 pages | October 2018 | by Isabelle Gagnon-Arpin, Ruben Vroegop, Thy Dinh
Cette note de recherche examine les intrants et les coûts qui se reflètent dans le prix de détail final des produits pharmaceutiques, aide à mieux comprendre les marges bénéficiaires...
Le Conference Board du Canada | 47 pages | October 2018 | by Isabelle Gagnon-Arpin, Ruben Vroegop, Thy Dinh
This was a free webinar.Cardiovascular disease (CVD) prevalence incurs significant costs to governments and society in the form of hospitalizations, disease management, and lost...
The Conference Board of Canada | Recorded Webinar | July 2017 | by Isabelle Gagnon-Arpin
(Displaying 1 to 20 of 27) | Page: 1 2 | Next »